Published online before print December 5, 2002, doi: 10.1161/01.STR.0000046457.54037.CC
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Stroke. 2003;34:28.)
© 2003 American Heart Association, Inc.
Original Contributions |
Inherited Thrombophilic Disorders in Young Adults With Ischemic Stroke and Patent Foramen Ovale
From Clinica Neurologica (A.P., E. D Z., M.M., A.C., N.M.A., L.A.V., A.P.), Clinica Cardiologica (D.A.), and III Laboratorio di Analisi, Biotecnologie (S.A., A.A.), Università degli Studi di Brescia, Brescia, Italia, and Istituto di Statistica Medica e Biometrie, Università degli Studi di Pavia, Pavia, Italia (M.G.).
Correspondence to Alessandro Pezzini, Clinica Neurologica, Università degli Studi di Brescia, P. le Spedali Civili, 1, 25100 Brescia, Italia. E-mail ale_pezzini{at}hotmail.com
Background and Purpose— The pathogenic link between patent foramen ovale (PFO) and stroke remains unknown in most cases. We investigated the association between inherited thrombophilic disorders and PFO-related strokes in a series of young adults in the setting of a case-control study.
Methods— We investigated 125 consecutive subjects (age, 34.7±7.3 years) with ischemic stroke and 149 age- and sex-matched control subjects. PFO was assessed in all patients with transcranial Doppler sonography with intravenous injection of agitated saline according to a standardized protocol. Genetic analyses for the factor V (FV)G1691A mutation, the prothrombin (PT)G20210A variant, and the TT677 genotype of methylenetetrahydrofolate reductase (MTHFR) were performed in all subjects.
Results— A pathogenic role of PFO was presumed in 36 patients (PFO+). Interatrial right-to-left shunt either was not detected or was considered unrelated to stroke occurrence in the remaining 89 patients (PFO-). The PTG20210A variant was more frequent in the PFO+ group compared with control subjects and the PFO- group (PFO+ versus control subjects, 11% versus 2%; 95% CI, 0.04 to 0.94; PFO+ versus PFO-, 11% versus 1.1%; 95% CI, 1.09 to 109; P=0.047). A similar distribution was observed for subjects carrying either the PTG20210A variant or the FVG1691A mutation (PFO+ versus control subjects, 19.4% versus 5.3%; 95% CI, 0.08 to 0.75; PFO+ versus PFO-, 19.4% versus 3.3%; 95% CI, 1.45 to 26.1; P=0.021). Combined thrombophilic defects were observed in 3 subjects of the PFO+ group, in 2 control subjects (8.3% versus 1.3%; 95% CI, 0.01 to 0.66; P=0.015), and in 0 subjects in the PFO- group. A trend toward a difference in the frequency of the FVG1691A mutation between PFO+ and control subjects was found after bivariate analysis (11% versus 3.3%; P=0.068) but not after multinomial logistic regression analysis. No significant association was found in the distribution of the TT MTHFR genotype in the 3 groups.
Conclusions— In young adults, the PTG20210A variant and, to a lesser extent, the FVG1691A mutation may represent risk factors for PFO-related cerebral infarcts. A role of systemic thrombophilic disorders in the pathogenesis of this specific subtype of stroke may be hypothesized.
Key Words: amine oxidoreductase • factor V • heart septal defects, atrial • prothrombin • stroke, ischemic
This article has been cited by other articles:
 |
|
 |
|
  M. R. Di Tullio, R. L. Sacco, R. R. Sciacca, Z. Jin, and S. Homma Patent Foramen Ovale and the Risk of Ischemic Stroke in a Multiethnic Population J. Am. Coll. Cardiol., February 20, 2007; 49(7): 797 - 802. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A Pezzini, M Grassi, E Del Zotto, D Assanelli, S Archetti, R Negrini, L Caimi, and A Padovani Interaction of homocysteine and conventional predisposing factors on risk of ischaemic stroke in young people: consistency in phenotype-disease analysis and genotype-disease analysis J. Neurol. Neurosurg. Psychiatry, October 1, 2006; 77(10): 1150 - 1156. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. B. Goldstein, R. Adams, M. J. Alberts, L. J. Appel, L. M. Brass, C. D. Bushnell, A. Culebras, T. J. DeGraba, P. B. Gorelick, J. R. Guyton, et al. Primary Prevention of Ischemic Stroke: A Guideline From the American Heart Association/American Stroke Association Stroke Council: Cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: The American Academy of Neurology affirms the value of this guideline. Stroke, June 1, 2006; 37(6): 1583 - 1633. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. L. Sacco, R. Adams, G. Albers, M. J. Alberts, O. Benavente, K. Furie, L. B. Goldstein, P. Gorelick, J. Halperin, R. Harbaugh, et al. Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association Council on Stroke: Co-Sponsored by the Council on Cardiovascular Radiology and Intervention: The American Academy of Neurology affirms the value of this guideline. Circulation, March 14, 2006; 113(10): e409 - e449. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Homma and R. L. Sacco Patent Foramen Ovale and Stroke Circulation, August 16, 2005; 112(7): 1063 - 1072. [Full Text] [PDF]
|
|
|
|
|
|
S. Cronin, K. L. Furie, and P. J. Kelly Dose-Related Association of MTHFR 677T Allele With Risk of Ischemic Stroke: Evidence From a Cumulative Meta-Analysis Stroke, July 1, 2005; 36(7): 1581 - 1587. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Iacoviello, A. Di Castelnuovo, M. Gattone, A. Pezzini, D. Assanelli, R. Lorenzet, E. Del Zotto, M. Colombo, E. Napoleone, C. Amore, et al. Polymorphisms of the Interleukin-1{beta} Gene Affect the Risk of Myocardial Infarction and Ischemic Stroke at Young Age and the Response of Mononuclear Cells to Stimulation In Vitro Arterioscler. Thromb. Vasc. Biol., January 1, 2005; 25(1): 222 - 227. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. P. Casas, A. D. Hingorani, L. E. Bautista, and P. Sharma Meta-analysis of Genetic Studies in Ischemic Stroke: Thirty-two Genes Involving Approximately 18 000 Cases and 58 000 Controls Arch Neurol, November 1, 2004; 61(11): 1652 - 1661. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Homma, M. R. DiTullio, R. L. Sacco, R. R. Sciacca, J.P. Mohr, and for PICSS Investigators Age As a Determinant of Adverse Events in Medically Treated Cryptogenic Stroke Patients With Patent Foramen Ovale Stroke, September 1, 2004; 35(9): 2145 - 2149. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Becker, E. Skalabrin, D. Hallam, and E. Gill Ischemic Stroke During Sexual Intercourse: A Report of 4 Cases in Persons With Patent Foramen Ovale Arch Neurol, July 1, 2004; 61(7): 1114 - 1116. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Pezzini, M. Grassi, E. Del Zotto, E. Bazzoli, S. Archetti, D. Assanelli, N. M. Akkawi, A. Albertini, and A. Padovani Synergistic Effect of Apolipoprotein E Polymorphisms and Cigarette Smoking on Risk of Ischemic Stroke in Young Adults Stroke, February 1, 2004; 35(2): 438 - 442. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. J. Rodriguez, S. Homma, R. L. Sacco, M. R. Di Tullio, R. R. Sciacca, and J.P. Mohr Race-Ethnic Differences in Patent Foramen Ovale, Atrial Septal Aneurysm, and Right Atrial Anatomy Among Ischemic Stroke Patients Stroke, September 1, 2003; 34(9): 2097 - 2102. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Stollberger, J. Finsterer, A. Pezzini, E. Del Zotto, and A. Padovani Search for Coagulopathy Does Not Obviate Search for Venous Thrombosis in Suspected Paradoxical Embolism * Response Stroke, September 1, 2003; 34 (9): e146 - e147. [Full Text] [PDF]
|
|
|
|
|
|
G. J. Hankey and J. W. Eikelboom Editorial Comment--Routine Thrombophilia Testing in Stroke Patients Is Unjustified Stroke, August 1, 2003; 34(8): 1826 - 1827. [Full Text] [PDF]
|
|
|
|
 |
|
 PFO, Inherited Coagulopathy, and Stroke Risk Journal Watch Neurology, May 9, 2003; 2003(509): 2 - 2. [Full Text]
|
|